The FDA highlights the importance of cefepime dose adjustments for patients with renal impairment.  Information identified through MedWatch has linked seizure risk to patients with renal impairment who inappropriately received non-adjusted doses of cefepime. As a pharmacist, how do you ensure your patients receive appropriately adjusted doses of medications?

 

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm309822.htm

Advertisements